Immunocompromised patients develop infections resulting from a wide ra
nge of organisms. The most commonly encountered type of infection is b
acterial in origin. Many of the infections are community-acquired pneu
monias in which most of the infections are caused by organisms that ty
pically produce disease in the healthy person. Hospital-acquired pneum
onias are particularly serious, being caused by the highly virulent gr
am-negative bacilli and Staphylococcus aureus. Immunocompromised patie
nts frequently have indwelling intravascular catheters. These catheter
s may become infected and seed the lung with septic emboli, producing
a hematogenous pneumonia. Underlying conditions and therapy increase t
he risk for aspiration in the immunocompromised patient. These aspirat
ions can result in the development of an aspiration pneumonia and lung
abscess formation. The majority of pneumonias resulting from Legionel
la and Nocardia occur in immunocompromised patients.